Market Overview

UPDATE: Bank of America Raises PT to $23 on Molina Healthcare Following Q3 Beat

Related MOH
Regardless Of Election Results, Bloomberg And Goldman Sachs Say Buy Stocks Linked To Federal Spending
Goldman Gives Molina Healthcare A Checkup, Upgrades To Neutral
ObamaCare Is Overpaying Insurers, Government Auditor Says (Investor's Business Daily)

Bank of America reiterated its Underperform rating on Molina Healthcare (NYSE: MOH) but raised its price target from $22 to $23.

Bank of America noted, "Overall, we are raising our 2013-2014 EPS estimates modestly to $1.40 (from $1.35) and $1.95 (from $1.90), respectively, since we already assumed Texas improvement in the out years. Our Underperform rating is based on a view that while MOH is well positioned for revenue growth, sustainable margins may just creep back to ~1.50% over time more inline with the company's 1.49% average since 2005."

Molina Healthcare closed at $22.73 on Tuesday.

Latest Ratings for MOH

Sep 2016Goldman SachsUpgradesSellNeutral
Sep 2016JefferiesMaintainsBuy
Aug 2016BarclaysTerminatesEqual-weight

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (MOH)

View Comments and Join the Discussion!